Literature DB >> 78946

Histamine release due to bivalent penicilloyl haptens: control by the basophil plasma membrane.

M Dembo, B Goldstein, A K Sobotka, L M Lichtenstein.   

Abstract

We describe the characteristics of in vitro histamine release from human basophils passively sensitized with serum from a penicillin-allergic individual. The histamine release is induced by a synthetic bivalent hapten, bis benzylpenicilloyl 1,6 diaminohexane (BPO)2. We present data on the effect of a monovalent hapten, benzylpenicilloyl formyl-L-lysine (BPO)1, on the histamine release. We also examine how histamine release depends on the concentration of serum used for passive sensitization, the source of cells used for passive sensitization, and the time allowed for histamine release. We interpret these experiments in terms of a theory of equilibrium binding of bivalent haptens to cell surface antibody that is presented in the previous paper. The results are consistent with the idea that the amount of histamine release is controlled by the number of cross-linked IgE molecules on the cell surface. In particular, the histamine dose-response curve rises because cross-links rise, has a maximum because the cross-links are a maximum, and falls because the cross-links fall.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 78946

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  Dimerization kinetics of the IgE-class antibodies by divalent haptens. I. The Fab-hapten interactions.

Authors:  R Schweitzer-Stenner; A Licht; I Pecht
Journal:  Biophys J       Date:  1992-08       Impact factor: 4.033

Review 2.  Cross-linking reconsidered: binding and cross-linking fields and the cellular response.

Authors:  B Sulzer; R J De Boer; A S Perelson
Journal:  Biophys J       Date:  1996-03       Impact factor: 4.033

3.  Allergy to carminic acid: in vitro evidence of involvement of protein-binding hapten.

Authors:  Mika Osumi; Masao Yamaguchi; Naoya Sugimoto; Maho Suzukawa; Hidenori Arai; Hiroshi Akiyama; Hiroyuki Nagase; Ken Ohta
Journal:  Asia Pac Allergy       Date:  2019-01-14

4.  Suppression of the basophil response to allergen during treatment with omalizumab is dependent on 2 competing factors.

Authors:  Donald W MacGlashan; Jessica H Savage; Robert A Wood; Sarbjit S Saini
Journal:  J Allergy Clin Immunol       Date:  2012-07-15       Impact factor: 10.793

5.  Equilibrium theory for the clustering of bivalent cell surface receptors by trivalent ligands. Application to histamine release from basophils.

Authors:  B Goldstein; A S Perelson
Journal:  Biophys J       Date:  1984-06       Impact factor: 4.033

6.  Theory of equilibrium binding of a bivalent ligand to cell surface antibody: the effect of antibody heterogeneity on cross-linking.

Authors:  B Goldstein; C Wofsy
Journal:  J Math Biol       Date:  1980-12       Impact factor: 2.259

7.  Quantifying aggregation of IgE-FcepsilonRI by multivalent antigen.

Authors:  W S Hlavacek; A S Perelson; B Sulzer; J Bold; J Paar; W Gorman; R G Posner
Journal:  Biophys J       Date:  1999-05       Impact factor: 4.033

8.  Modeling immunotherapy for allergy.

Authors:  M A Fishman; L A Segel
Journal:  Bull Math Biol       Date:  1996-11       Impact factor: 1.758

9.  A spatio-temporal model reveals self-limiting FcɛRI cross-linking by multivalent antigens.

Authors:  Md Shahinuzzaman; Jawahar Khetan; Dipak Barua
Journal:  R Soc Open Sci       Date:  2018-09-26       Impact factor: 2.963

10.  FceRI density and spontaneous secretion from human basophils.

Authors:  Donald MacGlashan
Journal:  PLoS One       Date:  2017-07-03       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.